A qualitative assessment of the challenges of WHO prequalification for anti-malarial drugs in China
Crossref DOI link: https://doi.org/10.1186/s12936-018-2303-8
Published Online: 2018-04-03
Published Print: 2018-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Huang, Yangmu
Pan, Ke
Peng, Danlu
Stergachis, Andy
Funding for this research was provided by:
National Natural Science Foundation of China (71503015)
Text and Data Mining valid from 2018-04-03
Article History
Received: 22 July 2017
Accepted: 26 March 2018
First Online: 3 April 2018